Greenwich LifeSciences, Inc.
GLSI· Nasdaq
Released Aug 14, 2024, after the close
10-Q filed Aug 14, 2024, 45 days after period end · 0001493152-24-032278
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$2.61M | -$1.63M | -$746.07K | -$749.75K |
| EPS Diluted | -$0.20 | -$0.13 | -$0.06 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end
+3.8% from the close of Aug 13, 2024 to the close of Aug 19, 2024, the first after the release.